Cargando…
Interleukin-17A in Alzheimer’s Disease: Recent Advances and Controversies
Alzheimer’s disease (AD) is a progressive neurodegenerative disease that mainly affects older adults. Although the global burden of AD is increasing year by year, the causes of AD remain largely unknown. Numerous basic and clinical studies have shown that interleukin-17A (IL-17A) may play a signific...
Autores principales: | Yan, Xin-Zhu, Lai, Laijun, Ao, Qiang, Tian, Xiao-Hong, Zhang, Yan-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413786/ https://www.ncbi.nlm.nih.gov/pubmed/34429057 http://dx.doi.org/10.2174/1570159X19666210823110004 |
Ejemplares similares
-
Epigenetics: Recent Advances and Its Role in the Treatment of Alzheimer's Disease
por: Xiao, Xuewen, et al.
Publicado: (2020) -
Interictal epileptiform discharges in Alzheimer’s disease: prevalence, relevance, and controversies
por: Lemus, Hernan Nicolas, et al.
Publicado: (2023) -
Natural Product-based Nanomedicine: Recent Advances and Issues for the Treatment of Alzheimer's Disease
por: Woon, Choy Ker, et al.
Publicado: (2022) -
Aducanumab as a Novel Treatment for Alzheimer’s Disease: A Decade of Hope, Controversies, and the Future
por: Esang, Michael, et al.
Publicado: (2021) -
Microglia-Derived Interleukin 23: A Crucial Cytokine in Alzheimer's Disease?
por: Nitsch, Louisa, et al.
Publicado: (2021)